311
Views
15
CrossRef citations to date
0
Altmetric
Reviews

Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence

, &
Pages 439-449 | Published online: 18 Oct 2022

References

  • AhnHSParkCMLeeSW2002The clinical relevance of sex hormone levels and sexual activity in the ageing maleBJU Int895263011942957
  • AllenDSWilsonSKKnappPM2004The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunctionJ Urol172652715247754
  • AnastasiadisAGGhafarMABurchardtM2002Economic aspect of medical erectile dysfunction therapiesExpert Opin Pharmacother32576311866676
  • AnguloJGadauMFernandezA2001IC351 enhances NO mediated relaxation of human arterial and trabecular penile smooth muscleEur Urol39suppl 5106
  • AtiemoHOSzostakMJSklarGN2003Salvage of sildenafil failures referred from primary care physiciansJ Urol1702356814634415
  • AversaAIsidoriAMDe MartinoMU2000Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunctionClin Endocrinol (Oxf)535172211012578
  • AversaAIsidoriAMCaprioM2002Penile pharmacotesting in diagnosing male erectile dysfunction: evidence for lack of accuracy and specificityInt J Androl2561011869371
  • BaileyDGDresserGK2004Interactions between grapefruit juice and cardiovascular drugsAm J Cardiovasc Drugs42819715449971
  • BallardSAGingellCJTangK1998Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterasis isozymesJ Urol1592164719598563
  • Behr-RousselDGornyDMevelK2004Chronic sildenafil enhances erectile responses and endothelium-dependent corporal relaxations of normal rats: Lack of tachyphylaxisJ Urol171425
  • BischoffE2004Potency, selectivity, and consequences of nonselectivity of PDE inhibitionInt J Impot Res16Suppl 1S11415224129
  • BrockGBMcMahonCGChenKK2002Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analysesJ Urol1681332612352386
  • BurnettALLowensteinCJBredtDS1992Nitric oxide: a physiologic mediator of penile erectionScience25740131378650
  • CappelleriJCRosenRCSmithMD1999Diagnostic evaluation of the Erectile Function domain of the International Index of Erectile FunctionUrology543465110443736
  • CarettaNPalegoPFerlinA2005Resumption of spontaneus erections in selected patients affected by erectile dysfunction and various degrees of of carotid wall alteration: role of tadalafilEur Urol483263216005378
  • CarosaEMartiniPBrandettiF2004Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levelsClin Endocrinol (Oxf)61382615355456
  • CarsonCCRajferJEardleyI2004The efficacy and safety of tadalafil: an updateBJU Int9312768115180622
  • CarsonCCShabsighRSegalS2005Efficacy, safety and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centersJ Urol653539
  • CoronaGMannucciEMansaniR2004Aging and pathogenesis of erectile dysfunctionInt J Impot Res1639540215164087
  • De RoseAFGalloFCarmignaniG2005Evaluation of sexual activity in patients treated with tadalafil: a randomized prospective placebo-controlled trialInt J Impot Res1776915510191
  • Del PopoloGLi MarziVMondainiN2004Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal chord-injured patientsSpinal Cord42643815289800
  • DerbyCABarbourMMHumeAL2001Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohortPharmacotherapy216768311401181
  • DishyVSofoworaGHarrisPA2001The effect of sildenafil on nitric oxide-mediated vasodilation in healthy menClin Pharmacol Ther70270911557915
  • EardleyIGentileVAustoniE2004Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunctionBJU Int94871715476525
  • EisenhardtASiffertW2003Genetic risk factors for erectile dysfunction and genetic determinants of drug response—on the way to improve drug safety?Herz283041312825146
  • El GalleyRRutlandHTalicR2001Long term efficacy of sildenafil and tachyphylaxis effectJ Urol1669273111490248
  • Eli Lilly Corporation2006Cialis (Tadalafil HCl) tablets: Prescribing information [online]. Accessed 14 February 2006. URL: http://www.cialis.com/
  • EllstromWJGOverstreetJWYuA2003Tadalafil has no detrimental effect on human spermatogenesis or reproductive hormonesJ Urol1708879112913723
  • EmmickJTStueweSRMitchellM2002Overview of the cardiovascular effects of tadalafilEur Heart J4H supplH3247
  • FeldmanHAGoldsteinIHatzichristouDG1994Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging StudyJ Urol15154618254833
  • FerriniGFValenteEGRajferJ2004Long-term treatment with high doses of sildenafil does not upregulate the levels of phosphodiesterase 5 (PDE-5) in the rat penisJ Urol171424
  • FonsecaVSeftelADenneJ2004Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data fromm tadalafil clinical trialsDiabetologia4719142315599697
  • FrajeseGPozziF2003New achievements and pharmacotherapeutic approaches to impotence in the elderlyAging Clin Exp Res152223314582685
  • FrajeseGVPozziF2005New achievement and novel therapeutic applications of PDE5 inhibithors in older malesJ Endocrinol Invest28suppl 3455016042360
  • GoldsteinILueTFPadma-NathanH1998Oral sildenafil in the treatment of erectile dysfunctionN Engl J Med33813974049580646
  • Hanson-DiversCJacksonSELueTF1998Health outcomes important to patients in the treatment of erectile dysfunctionJ Urol159154179554350
  • HarmanSMMetterEJTobinJD2001Longitudinal effects of aging on serum total and free testosterone levels in healthy menJ Clin Endocrinol Metab867243111158037
  • HatzichristouDVardiYPappG2005Effect of tadalafil on sexual timing behavior patterns in men with erectile dysfunction: integrated analysis of randomized, placebo controlled trialsJ Urol1741356916145426
  • JacksonGKlonerRACostiganTM2004Update on controlled clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse eventsJ Sex Med1161716422970
  • KlonerRAJacksonGEmmickJT2004Interaction between the phosphodiesterase 5 inhibitor tadalafil and 2 alpha-blockers, Doxazosin and tamsulosin in healthy normotensive menJ Urol17219354015540759
  • KlonerRAMitchellMEmmickJT2003Cardiovascular effects of tadalafilAm J Cardiol929A37M46M
  • KohsakaAWatanobeHKakizakiY1999Comparative study of the effects of nitric oxide and carbon monoxide on the in vivo release of gonadotropin-releasing hormone and neuropeptide Y from rat hypothalamus during the estradiol-induced luteinizing hormone surge: estimation by push-pull perfusionNeuroendocrinology692455310207276
  • KubinMWagnerGFugi-MeyerAR2003Epidemiology of erectile dysfunctionInt J Impot Res15637112605242
  • LewisRWSadovskyREardleyI2005The efficacy of tadalafil in clinical populationsJ Sex Med25173116422847
  • LinCSChowSLauATU R2002Human PDE5A gene encodes three PDE5 isoforms from two alternate promotersInt J Impot Res14152411896473
  • MazurA1998Aging and endocrinologyScience27930569454318
  • McMahonCG2002High dose sildenafil citrate as a salvage therapy for severe erectile dysfunctionInt J Impot Res14533812494291
  • McMahonCG2004Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafilJ Sex Med129230016422959
  • MeulemanE2002Prevalence of erectile dysfunction: need for treatment?Int J Impot Res14Suppl 1S22811850731
  • MironeVCostaPDamberJE2005An evaluation of an alternative dose regimen with tadalafil, 3 times/week, for men with erectile dysfunction: SURE Study in 14 European CountriesEur Urol478465415925082
  • MoncadaIDamberJEMironeV2005Sexual intercourse attempt patterns with two dosing regimens of tadalafil in men with erectile dysfunction: results from the SURE Study in 14 European countriesJ Sex Med26687416422825
  • MontorsiFPadma-NathanHMc CulloughA2004Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatecomy: a randomized, double-blind, placebo controlled trialJ Urol17210364115311032
  • MontorsiFVerheydenBMeulemanE2004Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunctionEur Urol4533944discussion 344–5.15036680
  • MorelandRBGoldsteinIKimNN1999Sildenafil citrate, a selective phosphodiesterase type 5 inhibitorTrends Endocrinol Metab109710410322402
  • MorelandRBHsiehGNakaneM2001The biochemical and neurologic basis for the treatment of male erectile dysfunctionJ Pharmacol Exp Ther36173
  • MorleyJE2001Androgens and agingMaturitas38617311311591
  • MulhallJP2003Deciphering erectile dysfunction drug trialsJ Urol170353812853774
  • [NIH] National Institutes of Health1992Impotence. NIH Consensus statement [online]. Accessed 14 February 2006. URL: http://consensus.nih.gov/1992/1992Impotence091html.htm
  • ParazziniFMenchini FabrisFBortolottiA2000Frequency and determinants of erectile dysfunction in ItalyEur Urol3743910671784
  • PattersonBBeddingAForgueST2001Dose normalized pharmacokinetics of single-dose tadalafil (IC351) in healthy volunteersInt J Impot Res13suppl. 5S62
  • PincusSMMulliganTIranmeshA1996Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously than younger males: dual novel facetsProc Natl Acad Sci U S A931410005
  • PincusSMVeldhuisJDMulliganT1997Effects of age on the irregularity of LH and FSH serum concentration in women and menAm J Physiol273E989959374686
  • PorstHPadma NathanHGiulianoF2003Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trialUrology62121612837435
  • RosanoGMCAversaAVitaleC2004Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular riskEur Urol4721422
  • RosenRCRileyAWagnerG1999The International Index of Erectile Function (IIEF): a multidimensional scale of assessment of erectile dysfunctonUrology5434610443736
  • RosenRCPadma-NathanHShabsighR2001Cialis (IC351) provides prompt response and extended period of responsiveness for the treatment of men with erectile dysfunction (ED)Abstracts of the 96th Annual Meeting of the American Urological AssociationJune 2–7, 2001Anaheim, California
  • RosenRCPadma-NathanHShabsighR2004Determining the earliest time within 30 minutes to erectogenic effect after tadalafil 10 and 20mg: A multicenter, randomized, double–blind, placebo controlled, at home studyJ Sex Med119320016422974
  • RubinowDSchmidtP1996Androgens, brain and behaviorAm J Psychiatry153974848678193
  • Saenz de TejadaIGoldsteinIAzadzoiK1989Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotenceN Engl J Med3201025302927481
  • Saenz De TejadaIAnglinGKnightJR2002Effects of tadalafil on erectile dysfunction in men with diabetesDiabetes Care2521596412453954
  • SeftelADFarberJFletcherJ2005A three-part study to investigate the incidence and potential etiologies of tadalafil-associated back pain or myalgiaInt J Impot Res174556116034469
  • SimonsenU2002Interactions between drugs for erectile dysfunction and drugs for cardiovascular diseaseInt J Impot Res141788812058245
  • ShabsighRBurnettALEardleyI2005Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trialsBJU Int968576316153217
  • ShulmanCCShenWStothardDR2004Integrated analysis examining first-dose success, success by dose and maintenance of success among men taking tadalafil for erectile dysfunctionJ Urol6478388
  • SkoumalRChenJKrzysztofK2004Efficacy and treatment satisfaction whit on demand tadalafil (Cialis) in men with erectile dysfunctionEur Urol46362915306109
  • SteersWD2000Neural pathways and central sites involved in penile erection: neuroanatomy and clinical implicationsNeurosci Biobehav Rev245071610880817
  • SullivanMEKeoghaneSRMillerMA2001Vascular risk factors and erectile dysfunctionBJU Int878384511412223
  • TsujimuraAYamanakaMTakahashiT2002The clinical studies of sildenafil for the ageing maleInt J Androl25283311869374
  • VelardezMODe LaurentiisADel Carmen DiazM2000Role of phosphodiesterase and protein kinase G on nitric oxide-induced inhibition of prolactin release from the rat anterior pituitaryEur J Endocrinol1432798410913949
  • ViragRBoullyPFrydmanD1985Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent menLancet26110910